Skip to main content
Log in

Depressive syndromes in schizophrenic patients after discharge from hospital

  • Original Articles
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Summary

A total of 364 schizophrenic outpatients who were stabilized for 3 months on continuous neuroleptic therapy after discharge from the hospital were rated according to three different scales for depressive syndromes (Brief Psychiatric Rating Scale anxious depression factor, AMDP/depression, and the self-rating PD-S depression scale). Between 19.5% and 27.5% of the patients were rated as depressed, or 35.7%–42.8%, when mild depressive syndromes were included. There were low, but significant correlations between demographic or life-event data and depression scores on the self-rating scale, whereas fewer correlations were found on the observer ratings. No associations were found between social adjustment and depression. Moderate correlations were found between measures of the apathetic syndrome and depression ratings, while observer ratings showed higher correlations than the self-rating. High depression scores, especially in the observer ratings, correlated with scales for global psychopathological assessment (CGI, GAS). There were significant correlations between extrapyramidal rigidity and observer rating depression scores, whereas the total amount of neuroleptics given had no influence. These results are interpreted on the basis of hypotheses about depressive syndromes in schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allebeck P, Varia A, Kristjansson E, Wistedt B (1987) Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand 76:414–419

    Google Scholar 

  2. Barnes TRE, Curson DA, Liddle PF, Patel M (1989) The nature and prevalence of depression in chronic schizophrenic in patients. Br J Psychiatry 154:486–491

    Google Scholar 

  3. Bartels SJ, Drake RE (1988) Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 29:467–483

    Google Scholar 

  4. Becker RE (1970) Evaluation of an amitriptyline-perphenazine combination in chronic schizophrenia. Am J Psychiatry 127:827–831

    Google Scholar 

  5. Becker RE (1983) Implications of the efficacy of thiotixene and a chlorpromazine-imipramine combination for depression in schizophrenia. Am J Psychiatry 140:208–211

    Google Scholar 

  6. Becker RE, Colliver JA, Verhulst SJ (1985) Diagnosis of secondary depression in schizophrenia. J Clin Psychiatry 46:9–13

    Google Scholar 

  7. Becker RE, Singh MM, Meisler N, Shillcut S (1985) Clinical significance, evaluation, and management of secondary depression in schizophrenia. J Clin Psychiatry 46:26–32

    Google Scholar 

  8. Berrios GE, Bulbena A (1987) Post psychotic depression: the Fulbourn cohort. Acta Psychiatr Scand 76:89–93

    Google Scholar 

  9. Black DW, Winokur G, Warrack G (1985) Suicide in schizophrenia: the Iowa Record Linkage Study. J Clin Psychiatry 46:14–17

    Google Scholar 

  10. Bleuler E (1911) Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg B (ed) Handbuch der Psychiatrie. Deuticke, Leipzig, pp 172–173

    Google Scholar 

  11. Conrad K (1987) Die beginnende Schizophrenie. Thieme, Stuttgart, p 81

    Google Scholar 

  12. Craig TJ, Natta P van (1976) Recognition of depressed affect in hospitalized psychiatric patients: staff and patient preceptions. Dis Nerv Syst 37:561–566

    Google Scholar 

  13. Donlon PT, Rada RT, Arora KK (1976) Depression and the reintegration of acute schizophrenia. Am J Psychiatry 133: 1265–1268

    Google Scholar 

  14. Drake RE, Cotton PG (1986) Depression, hopelessness and suicide in chronic schizophrenia. Br J Psychiatry 148:554–559

    Google Scholar 

  15. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766–771

    Google Scholar 

  16. Fähndrich E (1982) Schlafentzug-Behandlung depressiver Syndrome bei schizophrener Grunderkrankung. Nervenarzt 53:279–283

    Google Scholar 

  17. Galdi J, Reider RO, Silber D, Bonato RR (1981) Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study. Psychol Med 11:713–728

    Google Scholar 

  18. Gebhardt R, Pietzcker A, Strauss A, Stoeckel M, Langer C, Freudenthal K (1983) Skalenbildung im AMDP-System. Arch Psychiatr Nervenkr 233:223–245

    Google Scholar 

  19. Goplerud E, Depue RA (1978) The diagnostic ambiguity of postpsychotic depression. Schizophr Bull 4:477–479

    Google Scholar 

  20. Guy W, Ban TA (1982) AMPD-System. Manual for the assessment and documentation of psychopathology. Springer, Berlin Heidelberg New York

    Google Scholar 

  21. Häfner H (1989) Ist Schizophrenie eine Krankheit? Epidemiologische Daten und spekulative Folgerungen. Nervenarzt 60:191–199

    Google Scholar 

  22. Heinrich K (1960) Die gezielte Symptomprovokation mit monoaminooxidasehemmenden Substanzen in Diagnostik und Therapie schizophrener Psychosen. Nervenarzt 31:507

    Google Scholar 

  23. Heinrich K (1967) Zur Bedeutung des postremissiven Erschöpfungs-Syndroms für die Rehabilitation Schizophrener. Nervenarzt 38:487–491

    Google Scholar 

  24. Helmchen H, Hippius H (1967) Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt 38:455–458

    Google Scholar 

  25. Hirsch SR (1982) Comments. Depression ‘revealed’ in schizophrenia. Br J Psychiatry 142:421–423

    Google Scholar 

  26. Hogarty GE, Munetz MR (1984) Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate. J Clin Pharmacol 4:17–24

    Google Scholar 

  27. House A, Bostock J, Cooper U (1987) Depressive syndromes in the year following onset of a first schizophrenic illness. Br J Psychiatry 151:773–779

    Google Scholar 

  28. Jeste DV, Karson CN, Wyatt RJ (1984) Movement disorders and psychopathology. In: Jeste DV, Wyatt RJ (eds) Neuropsychiatric movement disorders. American Psychiatric Publications, Washington, D.C.

    Google Scholar 

  29. Johnson DAW (1981) Depression in schizophrenia: some observations in prevalence, etiology, and treatment. Acta Psychiatr Scand [Suppl.] 63:291

    Google Scholar 

  30. Johnson DAW (1981) Studies of depressive symptoms in schizophrenia. II. A two-year longitudinal study of symptoms. Br J Psychiatry 139:93–96

    Google Scholar 

  31. Johnson DAW (1981) Studies of depressive symptoms in schizophrenia. III. A double-blind trial of orphenadrine against placebo. Br J Psychiatry 139:96–97

    Google Scholar 

  32. Knights A, Hirsch SR (1981) ‘Revealed’ depression and drug treatment for schizophrenia. Arch Gen Psychiatry 38:806–811

    Google Scholar 

  33. Kraepelin E (1913) Psychiatrie, vol III, part II, 3rd edn. Abel, Leipzig

    Google Scholar 

  34. Kramer MS, Vogel WH, DiJohnson C, Dewey DA, Sheves P, Cavicchia S, Litle P, Schmidt P, Kimes I (1989) Antidepressants in ‘depressed’ schizophrenic inpatients. Arch Gen Psychiatry 46:922–928

    Google Scholar 

  35. Mandel MR, Severe JB, Schooler NR, Gelenberg AJ, Mieske M (1982) Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 39:197–203

    Google Scholar 

  36. Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment and Parkinson disease. Neurology 31:645–650

    Google Scholar 

  37. McGlashan TH (1982) Aphanisis: the syndrome of pseudodepression in chronic schizophrenia. Schizophr Bull 8:118–134

    Google Scholar 

  38. McGlashan TH, Carpenter WT (1976) An investigation of the postpsychotic depressive syndrome. Am J Psychiatry 133:14–19

    Google Scholar 

  39. Miles CP (1977) Conditions predisposing to suicide: a review. J Nerv Ment Dis 164:275–280

    Google Scholar 

  40. Möller HD, Zerssen D von (1981) Depressive Symptomatik im stationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmakopsychiatrie 14:172–179

    Google Scholar 

  41. Möller HJ, Zerssen D von (1982) Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull 8:109–117

    Google Scholar 

  42. Möller HJ, Zerssen D von (1986) Depression in schizophrenia. In: Burrows GD, Norman TR, Rubinstein G (eds) Handbook of studies on schizophrenia, part I. Elsevier, Amsterdam, pp 183–191

    Google Scholar 

  43. Müller P (1981) Depressive Syndrome im Verlauf schizophrener Erkrankungen. Enke, Stuttgart

    Google Scholar 

  44. Müller P (1990) Neuroleptika-induzierte Depressionen — Tatsache oder Fiktion? In: Heinrich K (ed) Leitlinien neuroleptischer Therapie. Springer, Berlin

    Google Scholar 

  45. NIMH — National Institute of Mental Health (1976) 028 CGI. Clinical Global Impressions. In: Guy W, Bonato RR (eds) ECDEU assessment manual for psychopharmacology. Rev Ed, Rockville, Maryland, pp 217–222

  46. Overall JE, Gorham DR (1976) 047 BPRS. Brief Psychiatric Rating Scale. In: Guy W (ed) ECDEU assessment manual for psychopharmacology. Rev Ed, Rockville, Maryland, pp 157–169

  47. Overall JE, Hollister LE, Pichot P (1967) Major psychiatric disorders. A four-dimensional model. Arch Gen Psychiatry 16:146–151

    Google Scholar 

  48. Pietzcker A, Gebhardt R, Strauss A, Stöckel M, Langer C, Freudenthal K (1983) The syndrome scales in the AMDP-system. Mod Probl Pharmacopsychiat, vol 20. Karger, Basel, pp 88–99

    Google Scholar 

  49. Pietzcker A, Gaebel W, Köpke W, Linden M, Müller P, Müller-Spahn F, Schüssler G, Tegeler J (1986) A German multicenter study on neuroleptic long-term therapy of schizophrenic patients. Preliminary report. Pharmacopsychiatry 19:161–166

    Google Scholar 

  50. Prasad AJ, Kumar N (1988) Suicidal behavior in hospitalized schizophrenics. Suicide Life-threat Behav 18:265–269

    Google Scholar 

  51. Prosser ES, Csernansky JG, Kaplan J, Thieman S, Becker TJ, Hollister LE (1987) Depression, Parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J Nerv Ment Dis 175:100–105

    Google Scholar 

  52. Prusoff BA, Williams DH, Weissman MM, Astrachan BM (1979) Treatment of secondary depression in schizophrenia. Arch Gen Psychiatry 36:569–575

    Google Scholar 

  53. Quitkin F, Rifkin A, Kane J, Romas-Lorenzi JR, Klein D (1978) Long-acting oral vs injectable antipsychotic drugs in schizophrenics. Arch Gen Psychiatry 35:889–892

    Google Scholar 

  54. Rifkin A, Quitkin F, Klein DF (1975) Akinesia. A poorly recognised drug-induced extrapyramidal behavioral disorder. Arch Gen Psychiatry 32:672–674

    Google Scholar 

  55. Roy A, (1987) Risk factors for depression in schizophrenia. American Psychiatric Association Annual Convention, Chicago, May 1987, pp 123–127

  56. Salama AA (1988) Depression and suicide in schizophrenicients. Suicide Life-threat Behav 18:379–384

    Google Scholar 

  57. Sheldrick C, Jablensky A, Sartorius N, Shepherd M (1977) Schizophrenia succeeded by affective illness: catamnestic study and statistical enquiry. Psychol Med 7:619–624

    Google Scholar 

  58. Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand [Suppl] 212:11–19

    Google Scholar 

  59. Siris SG, Strahan A (1988) Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression. J Clin Psychiatry 49:439–440

    Google Scholar 

  60. Siris SG, Kammen DP van, Docherty JP (1978) Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 35: 1368–1377

    Google Scholar 

  61. Siris SG, Harmon GK, Endicott J (1981) Postpsychotic depressive syndromes in hospitalized schizophrenic patients. Arch Gen Psychiatry 38:1122–1123

    Google Scholar 

  62. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB (1987) Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. Arch Gen Psychiatry 44:533–539

    Google Scholar 

  63. Siris G, Adan F, Cohen M, Mandeli J, Aronson A, Casey E (1988) Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 145:1532–1537

    Google Scholar 

  64. Siris SG, Sellew AP, Frechen K, Cooper TB, Mandell J, Casey E (1988) Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations. Clin Chem 35:837–840

    Google Scholar 

  65. Strauss JS, Carpenter WT (1972) The prediction of outcome in schizophrenia. Arch Gen Psychiatry 27:739–746

    Google Scholar 

  66. Strian F, Klicpera C (1983) Anxiety in schizophrenic patients. Arch Psychiatr Nervenkr 233:347–357

    Google Scholar 

  67. Tsuang MT, Woolson RF, Fleming JA (1980) Premature deaths in schizophrenia and affective disorders. Arch Gen Psychiatry 37:979–983

    Google Scholar 

  68. Van Kammen DP, Alexander PE, Bunney WE (1980) Lithium treatment in post-psychotic depression. Br J Psychiatr 136: 479–485

    Google Scholar 

  69. Van Putten T, May PRA (1978) ‘Akinetic depression’ in schizophrenia. Arch Gen Psychiatry 35:1101–1123

    Google Scholar 

  70. Von Zerssen D, Koeller DM (1976) Paranoid-Depressivitätsskala. Manual. Beltz, Munich

    Google Scholar 

  71. Weissman MM, Pottenger M, Kleber H, Ruben H, Williams D, Thompson WD (1977) Symptom pattern in primary and secondary depression. Arch Gen Psychiatry 34:854–862

    Google Scholar 

  72. Wistedt B (1984) 4-Jahres-Katamnesen bei behandelten und nicht behandelten chronisch schizophrenen Patienten in der Ambulanz. In: Kryspin-Exner K, Hinterhuber H, Schubert H (eds) Langzeittherapie psychiatrischer Erkrankungen. Schattauer, Stuttgart

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bandelow, B., Müller, P., Gaebel, W. et al. Depressive syndromes in schizophrenic patients after discharge from hospital. Eur Arch Psychiatry Clin Nuerosci 240, 113–120 (1990). https://doi.org/10.1007/BF02189981

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02189981

Key words

Navigation